Trademark: 97347180
Status Date
Tuesday, November 14, 2023
Filing Date
Tuesday, April 5, 2022
Published for Opposition
Tuesday, March 21, 2023
5 Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals
1 Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use
44 Medical services; medical information; providing a website featuring medical information
42 Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
Nov 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 14, 2023
Sou Extension 1 Granted
Nov 14, 2023
Sou Extension 1 Filed
Nov 14, 2023
Sou Teas Extension Received
May 16, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 21, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 21, 2023
Published For Opposition
Mar 1, 2023
Notification Of Notice Of Publication E-Mailed
Feb 15, 2023
Approved For Pub - Principal Register
Feb 14, 2023
Teas/Email Correspondence Entered
Feb 13, 2023
Correspondence Received In Law Office
Feb 13, 2023
Teas Request For Reconsideration Received
Jan 19, 2023
Notification Of Final Refusal Emailed
Jan 19, 2023
Final Refusal E-Mailed
Jan 19, 2023
Final Refusal Written
Nov 10, 2022
Teas/Email Correspondence Entered
Nov 10, 2022
Correspondence Received In Law Office
Nov 10, 2022
Teas Response To Office Action Received
May 31, 2022
Notification Of Non-Final Action E-Mailed
May 31, 2022
Non-Final Action E-Mailed
May 31, 2022
Non-Final Action Written
May 23, 2022
Assigned To Examiner
Apr 11, 2022
New Application Office Supplied Data Entered
Apr 8, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
